Sequential rituximab and mepolizumab in eosinophilic granulomatosis with polyangiitis (EGPA): a European multicentre observational study

Ann Rheum Dis. 2022 Dec;81(12):1769-1772. doi: 10.1136/ard-2022-222776. Epub 2022 Jul 18.
No abstract available

Keywords: Biological Therapy; Epidemiology; Rituximab; Systemic vasculitis.

Publication types

  • Observational Study
  • Multicenter Study

MeSH terms

  • Antibodies, Monoclonal, Humanized / therapeutic use
  • Churg-Strauss Syndrome* / drug therapy
  • Granulomatosis with Polyangiitis* / drug therapy
  • Humans
  • Rituximab / therapeutic use

Substances

  • Rituximab
  • mepolizumab
  • Antibodies, Monoclonal, Humanized